Atlas Trials

Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT00488709 · COMPLETED

Trial details

NCT number
NCT00488709
Sponsor
PETHEMA Foundation
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2003-05-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.